David M. Geliebter
Gründer bei Embark Healthcare
Ursprung des Netzwerks ersten Grades von David M. Geliebter
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA.
10
| Holding Company | Medical Specialties | 10 |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Woolsey Pharmaceuticals, Inc.
 Woolsey Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Embark Healthcare
 Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York.
2
| Private Company | Investment Managers | 2 |
Martin Pharmaceuticals, Inc.
 Martin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Martin Pharmaceuticals, Inc. engages in manufacturing, fabricating and processing drugs. The company was founded by David M. Geliebter and Sven M. Jacobson and is headquartered in New York, NY.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David M. Geliebter
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Director/Board Member | |
| ALERE INC | Medical Specialties | Sales & Marketing | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Valo Health, Inc.
 Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Financial Conglomerates | Director/Board Member | |
| TRINITY BIOTECH PLC | Medical Specialties | Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
| Brunel University | College/University | Graduate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
MacAndrews & Forbes Holdings, Inc.
 MacAndrews & Forbes Holdings, Inc. Investment ManagersFinance MacAndrews & Forbes Holdings, Inc. (MacAndrews & Forbes) is a private equity firm founded in 1984 by Ronald Perelman. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Diagnostic Hybrids, Inc.
 Diagnostic Hybrids, Inc. Medical SpecialtiesHealth Technology Diagnostic Hybrids, Inc. develops, manufactures and markets cellular and molecular diagnostic kits. Its products include rapid diagnostics, thyroid testing solutions, respiratory family testing, herpes family testing, chlamydia testing, enterovirus testing, cell lines and media and supplements. The company was founded by Wilfred R. Konneker, Joseph Jollick and Thomas E. Wagner in 1983 and is headquartered in Athens, OH. | Medical Specialties | Director/Board Member | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Michigan | College/University | Undergraduate Degree | |
| Western Michigan University | College/University | Graduate Degree Graduate Degree | |
| Westmont College | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
| New York Medical College | College/University | Graduate Degree | |
Booz Allen Hamilton International (U.K.) Ltd.
 Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer | |
Microvisk Ltd.
 Microvisk Ltd. Electronic Equipment/InstrumentsElectronic Technology Microvisk Ltd. engages in the manufacture and development of micro-viscometer based on micro electro mechanical sensors technology for medical field. The firm's products include CoagMax, CoagLite, CoagManager and SmartStrip. It develops technology for the detection and analysis of a fluid's properties using a cantilever-based micro-viscometer. The company was founded by Vladislav Djakov, Paul Morgan Vernon and Jeremy Burford Peckham in 2004 and is headquartered in Oxford, the United Kingdom. | Electronic Equipment/Instruments | Corporate Officer/Principal | |
| Helena Biosciences Ltd. | Corporate Officer/Principal | ||
| ADVICENNE | Pharmaceuticals: Generic | Chairman | |
| AXCA HEALPAR | Biotechnology | Chairman | |
| Columbia Business School | College/University | Masters Business Admin | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
| Ernest Mario School of Pharmacy | College/University | Undergraduate Degree | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
| The Cass Foundation | Director/Board Member | ||
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
| RUBIUS THERAPEUTICS | Biotechnology | Chairman | |
vTv Therapeutics LLC
 vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Sund Capital ApS
 Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer | |
| Remedii LLC | Corporate Officer/Principal | ||
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Pharmaceuticals: Major | Director/Board Member | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member | |
Pelican Harbor Seabird Station, Inc.
 Pelican Harbor Seabird Station, Inc. Agricultural Commodities/MillingProcess Industries Pelican Harbor Seabird Station, Inc. is an animal care organization that focuses on the rehabilitation of vultures, which are the only known obligate scavengers in the world. Pelican Harbor Seabird Station is based in Miami. The organization offers behind-the-scenes tours, honorary adoptions, internships, and school & camp presentations. The American company also provides resources & referrals, seabird cruises, and self-guided audio tours. In addition, they have a photobiomodulation (PBMT) program that uses light therapy to relieve pain and inflammation. | Agricultural Commodities/Milling | Chairman | |
| OPY ACQUISITION CORP. I | Financial Conglomerates | Director/Board Member | |
| Three Opinions Foundation, Inc. | Director/Board Member | ||
| SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| Think Pink Rocks | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 34 |
| Vereinigtes Königreich | 9 |
| Schweiz | 4 |
| Frankreich | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 63 |
| Corporate Officer/Principal | 30 |
| Chief Executive Officer | 23 |
| Independent Dir/Board Member | 15 |
| Undergraduate Degree | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Epstein | 30 |
| David Solomon | 22 |
| Richard Nelson | 21 |
| Kurt Landgraf | 18 |
| Roger Ulrich | 17 |
| Richard Steinhart | 12 |
| Patrick Arensdorf | 9 |
| James Snider | 8 |
| Sven M. Jacobson | 8 |
| Claude A. Piché | 7 |
| Richard Hughes | 6 |
| Ibrahim Mian | 5 |
| J. Marc Simard | 4 |
| Richard Dee | 3 |
| Thomas Walker MacAllister | 2 |
- Börse
- Insiders
- David M. Geliebter
- Unternehmensverbindungen
